colchicine and familial Mediterranean fever Archives

Abstract Number: 2108 • ACR/ARHP Annual Meeting 2017
Colchicine Treatment May be Protective Against Ventricular Arrhythmias in FMF Patients
Aslı Gozek Ocal¹, Lutfi Ocal² and Mehmet Engin Tezcan³, ¹Internal Medicine, University of Medical Sciences Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey, ²Cardiology, University of Medical Sciences Kosuyolu Kartal Heart Training and Research Hospital, Istanbul, Turkey, ³Rheumatology, University of Medical Sciences Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey
Background/Purpose: Familial Mediterranean fever (FMF) is an autoinflammatory disease. Colchicine is used in FMF patients for preventing attacks and amyloidosis. There were conflicting reports as…
Abstract Number: 375 • ACR/ARHP Annual Meeting 2017
Controlled Discontinuation of Colchicine Therapy in Familial Mediterranean Fever Patients with Single MEFV Mutation
Yonatan Butbul Aviel¹, Shafe Fahoum² and Riva Brik³, ¹Department of Pediatrics B Pediatric Rheumatology Service, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel, Haifa, Israel, ²Department of Pediatrics B,, , Ruth Children's Hospital, Rambam Medical Center, Haifa, Israel, Pediatric Rheumatology Service, .Rappaport Faculty of Medicine, Technion-lsrael Institute of Technology, Haifa, Israel, ³Pediatrics, Rambam Medical Center, Haifa, Israel
Background/Purpose: Familial Mediterranean fever (FMF) traditionally has been considered an autosomal recessive disease; however, the diagnosis remains predominantly clinical, since mutations cannot always be identified…
Abstract Number: 262 • ACR/ARHP Annual Meeting 2015
Canakinumab Therapy in Patients with Familial Mediterranean Fever
Serdal Ugurlu¹, Emire Seyahi², Gulen Hatemi², Aysa Hacioglu¹, Humeyra Ozcan¹, Fatma Nihan Akkoc¹ and Huri Ozdogan², ¹Rheumatology, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ²Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
Background/Purpose: It has been reported that Canakinumab reduced the frequency of attacks in patients with Familial Mediterranean Fever (FMF) resistant to colchicine with no apparent…
Abstract Number: 1230 • ACR/ARHP Annual Meeting 2014
Efficacy of Interleukin-1 Targeting Drugs in Familial Mediterranean Fever Patients
Pinar Cetin¹, Ismail Sari¹, Betul Sozeri², Ozlem Cam², Merih Birlik¹, Fatos Onen¹, Nurullah Akkoc¹ and Servet Akar¹, ¹Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, ²Pediatrics, Ege University School of Medicine, Izmir, Turkey
Background/Purpose Familial Mediterranean fever (FMF) is an autosomal-recessive autoinflammatory disorder characterized by recurrent episodes of fever accompanied by sterile peritonitis. The most devastating complication of…
Abstract Number: 1208 • ACR/ARHP Annual Meeting 2013
Canakinumab In Patients With FMF
Serdal Ugurlu¹, Emire Seyahi¹, Gulen Hatemi², Ayse Hacioglu² and Huri Ozdogan², ¹Division of Rheumatology,Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ²Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
Background/Purpose: In a recent pilot study, it was reported that Canakinumab reduced the frequency of attacks in 9 patients with Familial Mediterranean Fever (FMF) resistant…

Abstracts tagged "colchicine and familial Mediterranean fever"

Colchicine Treatment May be Protective Against Ventricular Arrhythmias in FMF Patients

Controlled Discontinuation of Colchicine Therapy in Familial Mediterranean Fever Patients with Single MEFV Mutation

Canakinumab Therapy in Patients with Familial Mediterranean Fever

Efficacy of Interleukin-1 Targeting Drugs in Familial Mediterranean Fever Patients

Canakinumab In Patients With FMF